Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney - PubMed (original) (raw)
Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney
B Cancilla et al. Kidney Int. 1999 Dec.
Free article
Abstract
Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney.
Background: The permanent kidney, or metanephros, develops through a complex series of reciprocal inductive events and involves branching morphogenesis, tubulogenesis, angiogenesis, and tissue remodeling. Fibroblast growth factors (FGFs) are a family of growth and differentiation factors that have been implicated in metanephric development. FGFs exert their actions through tyrosine kinase receptors, FGFRs, which are encoded by four FGFR genes (FGFR1 through FGFR4).
Methods: Reverse transcriptase-polymerase chain reaction was used to detect the expression of FGFs and FGFRs in rat metanephroi from embryonic day (E) 14 to E21. Nonradioactive in situ hybridization was used to localize FGF1 mRNA in E20 rat metanephroi, and immunohistochemistry was used to localize FGFRs in E15 and E20 rat metanephroi.
Results: We detected the expression of mRNAs for FGF1 through FGF5, FGF7 through FGF10, and FGFR1 through FGFR4 (IIIb and IIIc splice variants) in rat metanephroi from E14 to E21. By in situ hybridization, FGF1 mRNA was detected in the nephrogenic zone, ureteric epithelium, and developing nephron elements. FGFR proteins were localized in a distinct pattern that altered with maturation. FGFR1 was widely distributed in developing metanephric epithelia and mesenchyme, but not in developing interstitium. FGFR2 was also widely distributed in nephron epithelia, particularly in proximal convoluted tubules, but was not detected in metanephric mesenchyme, mesenchymal condensates, or developing interstitium. FGFR3 was localized to mesenchymal condensates, nephron elements, and medullary interstitium but not proximal convoluted tubules. FGFR4 was localized mostly to maturing nephron structures and was not detected in nephrogenic mesenchyme, mesenchymal condensates, or developing interstitium.
Conclusions: These results indicate that FGFs and FGFRs are expressed in the developing rat metanephros from at least E14 and that they likely play important roles in metanephric development and maturation.
Similar articles
- Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung.
Powell PP, Wang CC, Horinouchi H, Shepherd K, Jacobson M, Lipson M, Jones R. Powell PP, et al. Am J Respir Cell Mol Biol. 1998 Oct;19(4):563-72. doi: 10.1165/ajrcmb.19.4.2994. Am J Respir Cell Mol Biol. 1998. PMID: 9761752 - Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis.
Qiao J, Bush KT, Steer DL, Stuart RO, Sakurai H, Wachsman W, Nigam SK. Qiao J, et al. Mech Dev. 2001 Dec;109(2):123-35. doi: 10.1016/s0925-4773(01)00592-5. Mech Dev. 2001. PMID: 11731227 - Role of fibroblast growth factor receptor signaling in kidney development.
Bates CM. Bates CM. Pediatr Nephrol. 2007 Mar;22(3):343-9. doi: 10.1007/s00467-006-0239-7. Epub 2006 Aug 24. Pediatr Nephrol. 2007. PMID: 16932896 Review. - Role of FGFRL1 and other FGF signaling proteins in early kidney development.
Trueb B, Amann R, Gerber SD. Trueb B, et al. Cell Mol Life Sci. 2013 Jul;70(14):2505-18. doi: 10.1007/s00018-012-1189-9. Epub 2012 Oct 31. Cell Mol Life Sci. 2013. PMID: 23112089 Free PMC article. Review.
Cited by
- Genome-wide association study of hospitalized patients and acute kidney injury.
Siew ED, Hellwege JN, Hung AM, Birkelo BC, Vincz AJ, Parr SK, Denton J, Greevy RA, Robinson-Cohen C, Liu H, Susztak K, Matheny ME, Velez Edwards DR. Siew ED, et al. Kidney Int. 2024 Aug;106(2):291-301. doi: 10.1016/j.kint.2024.04.019. Epub 2024 May 24. Kidney Int. 2024. PMID: 38797326 - Shared features in ear and kidney development - implications for oto-renal syndromes.
Wang SX, Streit A. Wang SX, et al. Dis Model Mech. 2024 Feb 1;17(2):dmm050447. doi: 10.1242/dmm.050447. Epub 2024 Feb 14. Dis Model Mech. 2024. PMID: 38353121 Free PMC article. - The potential function and clinical application of FGF21 in metabolic diseases.
Chen Z, Yang L, Liu Y, Huang P, Song H, Zheng P. Chen Z, et al. Front Pharmacol. 2022 Dec 21;13:1089214. doi: 10.3389/fphar.2022.1089214. eCollection 2022. Front Pharmacol. 2022. PMID: 36618930 Free PMC article. Review. - Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK, Singh N, Das M, Rawat J, Gupta DK. Sahu DK, et al. Pediatr Surg Int. 2022 Nov;38(11):1601-1617. doi: 10.1007/s00383-022-05202-2. Epub 2022 Sep 15. Pediatr Surg Int. 2022. PMID: 36107237 - A genome-wide scan to locate regions associated with familial vesicoureteral reflux.
Bartik Z, Sillén U, Östensson M, Fransson S, Djos A, Sjöberg R, Martinsson T. Bartik Z, et al. Exp Ther Med. 2022 Jan;23(1):92. doi: 10.3892/etm.2021.11015. Epub 2021 Nov 28. Exp Ther Med. 2022. PMID: 34976134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous